Surgery Partners Inc (NASDAQ:SGRY) COO Jason Eric Evans Purchases 25,000 Shares
Surgery Partners Inc (NASDAQ:SGRY) COO Jason Eric Evans acquired 25,000 shares of the stock in a transaction dated Tuesday, August 20th. The stock was acquired at an average price of $5.95 per share, for a total transaction of $148,750.00. Following the purchase, the chief operating officer now directly owns 111,655 shares in the company, valued at $664,347.25. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Surgery Partners stock traded up $0.15 during midday trading on Thursday, hitting $6.25. The stock had a trading volume of 9,969 shares, compared to its average volume of 458,088. The firm’s fifty day moving average is $7.09 and its two-hundred day moving average is $10.01. The company has a market capitalization of $301.83 million, a PE ratio of -2.59 and a beta of 2.27. Surgery Partners Inc has a 52-week low of $5.38 and a 52-week high of $18.50. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 2.29.
Surgery Partners (NASDAQ:SGRY) last released its earnings results on Wednesday, August 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.22) by ($0.13). The firm had revenue of $445.40 million during the quarter, compared to analysts’ expectations of $450.89 million. Surgery Partners had a negative return on equity of 4.65% and a negative net margin of 11.61%. The company’s revenue was up 2.0% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.57) earnings per share. As a group, equities research analysts predict that Surgery Partners Inc will post -0.86 earnings per share for the current fiscal year.
Several equities analysts have recently weighed in on SGRY shares. Zacks Investment Research cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Saturday, August 3rd. ValuEngine upgraded shares of Surgery Partners from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. BidaskClub cut shares of Surgery Partners from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 14th. Finally, Stifel Nicolaus set a $12.00 price objective on shares of Surgery Partners and gave the stock a “hold” rating in a research note on Wednesday, May 8th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $14.33.
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.